胸腔内注射碘伏在难治性气胸治疗中的应用  

Application of intrathoracic injection of iodophor in the treatment of refractory pneumothorax

作　　者：刘国清[1] 贺霞[1] 张春霞[1] 唐卓伟 殷鹭 Liu Guoqing;He Xia;Zhang Chunxia;Tang Zhuowei;Yin Lu(Department of Respiratory Medicine,the Second People's Hospital of Deyang City,Sichuan Deyang 618000)

机构地区：[1]德阳市第二人民医院呼吸内科

出　　处：《中国社区医师》2019年第35期52-52,54,共2页Chinese Community Doctors

摘　　要：目的:观察胸腔内注射碘伏或自体血治疗难治性气胸的临床疗效.方法:2017年7月收治难治性气胸患者30例,分为自体血组和碘伏组各15例.两组均行胸腔内闭式引流,且分别胸腔内注射自体血50 mL或碘伏20 mL.比较两组总有效率.结果:碘伏组总有效率显著高于自体血组,差异有统计学意义(P<0.05).结论:胸腔内注射碘伏可更有效地治疗难治性气胸.Objective:To observe the clinical effect of intrathoracic injection of iodophor or autologous blood in the treatment of refractory pneumothorax.Methods:In July 2017,30 patients with refractory pneumothorax were selected,they were divided into autologous blood group and iodophor group,15cases in each.Both groups underwent closed thoracic drainage and intrathoracic injection of autologous blood 50 mL or iodophor 20 mL.To compare the total efficiency of the two groups.Results:The total effective rate of the iodophor group was significantly higher than the autologous blood group,the difference was statistically significant(P<0.05).Conclusion:Intrathoracic injection of iodophor is more effective in the treatment of refractory pneumothorax.

关 键 词：碘伏 难治性气胸 自体血 

分 类 号：R73[医药卫生—肿瘤]